Circulation, Vol 63, 378-387, Copyright © 1981 by American Heart Association
JD Rutherford, SF Vatner and E Braunwald
The effects of aminophylline, 1 mg/kg/min infused intravenously for 10
minutes, were examined on left ventricular (LV) diameter, pressure, an
indexes of myocardial contractility, as well as systemic, coronary and
regional hemodynamics in conscious dogs. Aminophylline increased mean
arterial pressure 12 +/- 2%, LV systolic pressure 8 +/- 1%, LV dP/dt 20 +/-
2%, velocity of myocardial fiber shortening 13 +/- 2% and heart rate 5 +/-
2%, and reduced LV end-diastolic diameter 2 +/- 0.5%. Vascular resistance
rose in the systemic bed 13 +/- 5%, the coronary bed 26 +/- 3%, the
mesenteric bed 26 +/- 5% and the iliac bed 36 +/- 4%, but did not rise in
the renal bed. Both beta-adrenergic receptor blockade with propranolol and
chronic treatment with reserpine attentuated but did not abolish the
positive inotropic response induced by aminophylline. Alpha-adrenergic
receptor blockade with phentolamine prevented aminophylline-induced
vasoconstriction in the systemic, coronary, mesenteric and iliac beds. In
contrast to the vasoconstriction with i.v. aminophylline, when the drug was
infused directly into the iliac artery, it elicited marked iliac
vasodilation. Thus, in the intact conscious dog, i.v. aminophylline, in a
dose that had little effect on heart rate, increased LV contractility and
reduced preload. The increase in contractility was dependent in part on
intact beta-adrenergic nervous activity and endogenous catecholamine
stores. The increase in systemic, coronary, iliac and mesenteric
resistances involved alpha-adrenergic mechanisms. These actions appear to
involve autonomic mechanisms, because the only direct effect of
aminophylline on the iliac artery was marked vasodilation.
ARTICLES
Effects and mechanism of action of aminophylline on cardiac function and regional blood flow distribution in conscious dogs
This article has been cited by other articles:
![]() |
P. Bogaty, J. G. Kingma, J. Guimond, P. Poirier, L. Boyer, L. Charbonneau, and G. R. Dagenais Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon J. Am. Coll. Cardiol., February 1, 2001; 37(2): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Minton and J. Henry Acute and chronic human toxicity of theophylline Human and Experimental Toxicology, June 1, 1996; 15(6): 471 - 481. [PDF] |
||||
![]() |
T. Minamino, M. Kitakaze, T. Morioka, K. Node, Y. Shinozaki BE, M. Chujo, H. Mori, H. Takeda, M. Inoue, M. Hori, et al. Bidirectional Effects of Aminophylline on Myocardial Ischemia Circulation, September 1, 1995; 92(5): 1254 - 1260. [Abstract] [Full Text] |
||||
![]() |
T. E. KEARNEY, A. S. MANOGUERRA, G. P. CURTIS, and M. G. ZIEGLER Theophylline Toxicity and the Beta-Adrenergic System Ann Intern Med, June 1, 1985; 102(6): 766 - 769. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1981 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |